@Giguere_P@anish_koka@AnilMakam In my experience, the complicated part is the baseline risk for my individual patient. Hard to estimate and most of the time oncologists are too optimistic.
@DrToddLee@LucusHumphrey Well done ! If marathon now feels too easy and you want a different type of challenge, you can come to Switzerland and try the classic Sierre-Zinal mountain race ;)
For older adults w/ newly diagnosed afib during hospitalization the 1-yr stroke risk w/o anticoag was low: 0.7% for CHA2DS2VASc 1-4 & 1.8% for 5-8
Given consensus of ≥2%/year, anticoag may be less compelling in hospital-detected AF but should still be individualized by risk
@AnilMakam@DrToddLee Recurrence is frequent - 1/3 at 1y in the AFOTS trial, https://t.co/7ucEQ1A8Na, and probably influences stroke risque. I don't ac patients but share these data with them so that they are aware of the possibility of recurrence and of the need to see their GP if it occurs.
"The other evening, I received two normally welcome email alerts. The first informed me that an invitation to peer review had been accepted; the second, that a peer review had just been completed.
The problem? These two emails came seven minutes apart and concerned the same reviewer"
https://t.co/9xsvjfxlqG
Rethinking the routine: Are repeat blood cultures necessary after completion of infective endocarditis treatment?
✅ Just Accepted
🔗 https://t.co/z253GTWxds